Phases out certain reimbursements for expenditures made by or on behalf of social services districts for medical assistance for needy persons, beginning with a 10% reduction for 2025, and ending with a 100% reduction for 2034, and remaining eliminated for each year thereafter.
Establishes a small business tax credit for certain efforts taken to improve such small business's facility in an effort to reduce the spread of infectious diseases.
Relates to requiring telephones capable of making local and long-distance telephone calls be in every nursing home patient's room, either at such patient's bedside or in the patient's room depending on the patient's mobility.
Establishes the school safety specialist act; establishes a certification and training program for school safety specialists; outlines the roles and duties of school safety specialists.
Establishes the veterans' services organization capital support program to provide funding to eligible entities for payment of the capital costs of construction, improvement, repairs, rehabilitation, or reconstruction of facilities owned by eligible entities, and for the acquisition of related equipment with a useful life of not less than ten years; appropriates a sum of $10,000,000 therefor.
Increases the applicable percentage of the child tax credit allowed in the empire state child tax credit from thirty-three percent to forty-five percent; prescribes how such payment or refund should be made based on amount.
Includes entities that provide employment or services to formerly incarcerated persons in the preferred source exemption for purposes of state purchasing.
Provides that the comptroller shall examine and audit all state or federal funds appropriated or received for the humanitarian aid including short term shelter services to migrant individuals and families, including costs associated with humanitarian emergency response and relief centers for individuals entering short term shelter on or after April 1, 2024 in New York city or any other municipality in New York state.
Provides for the initiation of treatment for COVID-19, influenza, and pharyngitis resulting from a Group A streptococcal infection by a licensed pharmacist in certain circumstances.